For 20 years Tim Heverin has represented clients in high-value patent and trade secret disputes, often involving international actors, activity, and witnesses. In doing so he has appeared before district courts across the country, the Federal Circuit, the International Trade Commission (ITC), and the Patent Trial and Appeal Board (PTAB).
In particular, Tim has extensive experience litigating life science patent disputes. He has represented clients in matters concerning pharmaceutical and biologic products such as Prezista®, Hytrin®, Tricor®, Istodax®, and Kuvan®. He recently was part of the team that successfully defeated an institution of four inter partes reviews (IPRs) and defended a separate interference action related to formulation patents for the top-selling drug Humira®.
In addition to his pharmaceutical work, Tim has handled patent disputes relating to medical devices, chemical processing, semiconductor fabrication and function, microchip architecture, information theory and coding, and search and database mining.
Prior to attending law school, Tim worked in the U.S. Naval Nuclear Propulsion Program as a nuclear plant engineer at Knolls Atomic Power Laboratory's Kesselring site, where, among other things, he instructed Naval officers in nuclear plant operation and casualty response.
Fed. Cir. Dissent: Opening Brief Lacking Appointments Clause Mention Still Eligible for Remand, PTAB Litigation Blog
- January 2012
Jones Day Chicago hosts University of Illinois BLSA students in an informational panel
- University of Notre Dame (J.D. summa cum laude 1997; Articles Editor, Law Review; B.S.M.E. 1991)
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice